Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Influenza vax cost effective in children aged 2-5 years

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Influenza vax cost effective in children aged 2-5 years. Pharmacoecon. Outcomes News 496, 3 (2006). https://doi.org/10.2165/00151234-200604960-00004

    Download citation

    Keywords

    • Influenza
    • Influenza Virus
    • Outcome News
    • Healthy Child
    • Virus Vaccine